CERTAIN (Checklist for Early Recognition and Treatment of Acute Illness and iNjury) is designed and developed to standardize the approach to the evaluation and treatment of acutely decompensating patients. The design and content was informed by the survey of clinicians from diverse international settings. Available in electronic (laptop/mobile) and paper formats, CERTAIN provides evidence based diagnostic checklists, clinical decision support, educational modules on performing critical procedures, and has the ability to time and document real-time interventions. CERTAIN prompting has been shown to improve performance of clinical providers faced with simulated emergencies.
د/ماجد الوراقي
Structured approach for critically ill patient
المحاضرة التي قدمت يوم الاربعاء 9 ابريل 2014 في دار الحكمة بالقاهرة
من فعاليات مشروع اعداد طبيب حكيم ناجح بالتعاون مع معتمد باتحاد الاطباء العرب
و ضمن موديول الطوارئ و التخدير و العناية المركزة
د/ماجد الوراقي
Structured approach for critically ill patient
المحاضرة التي قدمت يوم الاربعاء 9 ابريل 2014 في دار الحكمة بالقاهرة
من فعاليات مشروع اعداد طبيب حكيم ناجح بالتعاون مع معتمد باتحاد الاطباء العرب
و ضمن موديول الطوارئ و التخدير و العناية المركزة
Airway manipulations and intubation are the potential to cause a high level of aerosolization in the emergency department. This presentation is giving an overview of how to perform protected intubation in the emergency department. It has prepared by using the available latest data on COVID 19 protected Intubation
Transport of critically ill patient in hospital is a great task and requires, a well trained team and if not carried out with precision can lead to life threatening accidents..
Presention on the Computerised real time automatic SAPS APACHE and SOFA score Calculation and display system implemented at JPNA Trauma Centre, AIIMS, New Delhi
Airway manipulations and intubation are the potential to cause a high level of aerosolization in the emergency department. This presentation is giving an overview of how to perform protected intubation in the emergency department. It has prepared by using the available latest data on COVID 19 protected Intubation
Transport of critically ill patient in hospital is a great task and requires, a well trained team and if not carried out with precision can lead to life threatening accidents..
Presention on the Computerised real time automatic SAPS APACHE and SOFA score Calculation and display system implemented at JPNA Trauma Centre, AIIMS, New Delhi
General anesthesia
HISTORY OF ANESTHESIA, ADVANTAGES AND DISADVANTAGES OF GENERAL ANESTHESIA, INDICATIONS AND CONTRAINDICATIONS OF GENERAL ANESTHESIA, PREOPERATIVE EVALUATION, PREANAESTHETIC MEDICATION, STAGES OF GENERAL ANESTHESIA, VITAL SIGNS, CLASSIFICATION OF GENERAL ANESTHESIA, ASA CLASSIFICATION, Isoflurane, Sevoflurane, Desflurane, Fentanyl , KETAMINE
How health analytics are changing the way we understand and manage healthcare. Presented by Professor Enrico Coiera, Faculty of Medicine at the University of NSW, Australia, at HINZ 2014, 11 November 2014, 10am, Plenary Room
Presentation slides from our first meeting, held on Tuesday 10th September 2013 at the Royal College of Surgeons.
Find us on
Twitter @STARSurgUK
Facebook.com/STARSurgUK
Email: STARSurgUK@gmail.com
ICN Victoria presents Dr Dashiell Gantner, research fellow at the Monash University in Melbourne. Here he talks about translating ICU research into clinical practice.
Polytrauma and multiple traumata are medical terms describing the condition of a person who has been subjected to multiple traumatic injuries. This will be more prevalent in our country
Back to the Bedside: Internal Medicine Bedside Ultrasound ProgramAllina Health
David Tierney, MD. How bedside ultrasound is changing the practice of medicine and how Abbott Northwestern Hospital has become a national leader in integrating bedside ultrasound in its Internal Medicine Residency Program. "As internal medicine physicians, we are finding that everything we do with our hands, eyes and stethoscopes can be done a little better with ultrasound. That means our physical exam, which we consider our bread and butter, has more sensitivity and specificity. This gives us better diagnostic ability and results in earlier and more appropriate treatment."
“Trauma” = Injury of one or more systems,that results in excessive bleeding and mayaffect the normal body functioning.
Defined as cellular disruption caused by anexchange with environmental energy that isbeyond the body's resilience.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Structured Approach to Critically Ill and Injured Patient
1. Structured Approach to Critically Ill and
Injured Patient
Dr Ognjen Gajic
Mayo Clinic
Rochester MN USA
Rochester MN, USA
Multidisciplinary Epidemiology and Translational Research in
Intensive Care (M.E.T.R.I.C.)
@ gajic.ognjen@mayo.edu
2. Critical care support for
potentially reversible acute illness
One of the most cost-effective healthcare
interventions
Incomplete
knowledge
Delayed, error-prone
care
delivery
3. Consequence of Error and Delay
“The most sophisticated intensive care
becomes unnecessarily expensive terminal
care…”
Peter Safar
Safar P. Critical care medicine – Quo Vadis? Crit Care Med 1974; 2:1–5
9. Hypothesis / Mission Statement
The care
assisted by prompting with decision
support tool (CERTAIN)
will improve the process and
outcome of acute critical illness
10. CERTAIN: Checklist for Early Recognition and
Treatment of Acute Illness
ELITE
Stabilization Module
ROUNDS
Optimization Module
Admission
Resuscitation
Rounding
http://www.icertain.org/
21. Remote education of bedside providers
• Baseline assessment
• Online training
• Video-assisted coaching and certification
– Transcontinental “screen share”
– Remote video communication (Google+)
22. Video-assisted coaching and certification
– Refreshing key aspects of online teaching
– Video assisted team training
Training Participant 1 Participant 2 Participant 3
Test Case 1A Team Leader Prompter Team Member
Test Case 2A Team Member Team Leader Prompter
Test Case 3A Prompter Team Member Team Leader
– Certification (scoring)
Certification Participant 1 Participant 2 Participant 3
Test Case 1B Team Leader Prompter Team Member
Test Case 2B Team Member Team Leader Prompter
Test Case 3B Prompter Team Member Team Leader
– Survey
23. Refining, customizing and updating decision
support content
• Systematic review of practice guidelines
– checklist drafts by investigators from various
backgrounds (anesthesiology, trauma surgery,
pediatrics, emergency and internal medicine)
• International survey of acute care providers
• Iterative review through a structured feedback
by users
25. PDSA (Plan-Do-Study-Act) quality improvement
Patient
Betterment
Concept
Introduction
Identification
of local
champions
Education
and Training
Data
Tool
Refinement
gathering and
Quality
improvement
and
Validation
26. Outcome assessment
Better
care
Adherence to basic critical care processes
(i.e. low tidal volume mechanical ventilation)
Better
health
Lower
cost
ICU, hospital and 28 days mortality
ICU and hospital length of stay
27. Advisory board
US Critical Illness and Injury Trials Group AACN
Outcome assessment
M Kojicic, Y Dong, D Talmor
ATS International Committee
ESICM Global Working Group
Refining, customizing and updating decision support
B Bonneton, C Schmickl, L Garcia, M Schultz, N Adhikari, R Kashyap
L Bucher, M Dunser, R Fowler, G Diverti, P Park, P Hou, S Senkal,
S Gavrilovic, O Kilickaya, O Gajic, all site investigators
Study Center I
Study Center II
Study Center III
Technical development
Lei Fan, O Kilickaya, V Herasevich, B Pickering
Education and Implementation
Y Dong, L Garcia, R Kashyap, M Kojicic,
K Harder, J O’Horo, M Gong
Study Center IV
Study Centers …N
A Gawande, Y Donchin, K Hillman, T Clemmer
CERTAIN Executive Committee
M Vukoja – Principal Investigator
R Kashyap – Co-PI (Project Manager)
L Bucher –Co-PI (AACN)
N Adhikari – Co-PI (ATS)
M Schultz – Co-PI (ESICM)
JC Farmer – Co-PI (SCCM)
O Gajic – Co-PI (USCIITG)
M Gong – Co-PI Implementation
D Talmor – Co-PI Outcome
L Fan – Technical Lead
Y Dong – Education and Training
Ancillary Projects
Simulation R Sevilla-Berios, J O’Horo
Cost effectiveness H Omanic
Commercialization Al Benning
29. - Unconscious
AND
- Apneic or gasping
CPR
Conceptual framework
Primary
Survey Address immediate life threats (ABCDE): Airway, Work of
Breathing, Poor Circulation (shock, arrhythmia), Disability (neuro-deficit,
seizure), Exposure (bleeding, acute abdomen, rash)
Focused history -
- Patient / EMS/
family
Point of care
diagnostics
- Ultrasound,
ECG, laboratory
Interventions
- Emergency interventions in
parallel with evaluation (Oxygen,
fluid, vasopressor, antiarrhytmic,
ventilator, cardioversion, pacing)
-Targeted intervention as
syndrome is defined (antibiotics)
-Refine based on response to
therapy and information
-Assure timely completion
Secondary
survey Syndrome recognition
- Generate problem list
- Review CERTAIN recommended
interventions for specific scenario
- Review differential diagnosis
When
Stabilized
System-based assessment and plan
Kilickaya O, Bonneton B, Gajic O. Yearbook of Intensive Care and Emergency Medicine 2014
30. Evaluate if you need to start CPR
• If the patient is unconscious and
gasping/apneic, STOP and move to BLS
protocol (CPR)
– These interventions are immediate and
should precede any further diagnostic
workup
31. • Organize your team
– Role assignment
– Assure effective communication
• Close loop communication
• Safety culture: speak up!
– Team dynamics
32. Start basic procedures as you inspect the patient
• Vital signs
• ECG monitor
• Pulse oximetry
• Obtain IV access
• Administer oxygen
• Point-of-care labs (glucose, pH, PaCO2, Hb, K+, Ca++, lactate)
37. • Exposure
• Abdomen distended?
• Obvious sources of blood loss?
• Gross rashes and wounds?
• Edema?
– Temperature
• Fever?
• Hypothermic?
38. • Always keep an eye on the
patient
• Communicate compassionately
to patient and/or family
– Hand holding and reassurance
• If an immediate threat is
detected at any time, go back
to primary survey
39. • Focused history
– Why are they here?
– Any relevant history?
– Relevant meds?
– Allergies?
48. Rounding Choreography
•Getting started
•Introduce self, establish roles
•Engage patient and/or family
•Explain rounding process
•Give permission to ask questions
•Encourage engagement
•Assign a prompter (=team member filling out CERTAIN checklist)
•Patient Presentation
•One-sentence summary of reason for ICU
•e.g. 56 year old man with background of alcoholic cirrhosis hospital day 7 for
septic shock from cellulitis complicated by ARDS and AKI
•One-sentence summary of last 24 hours events
•e.g. Emergent ETT exchange last night for acute obstruction by thick mucus
plug, otherwise uneventful
•Discuss pertinent findings, including negatives
•Systems based assessment and plan
•Daily goals of care
49. Rounding Choreography
•Systems based assessment and plan
•Before/during presentation
•Engage prompter to fill out CERTAIN checklist and to speak up if items are missed
•Encourage input from team members (close loop communication)
•Plan of care: Set specific goals
•Discuss items with the appropriate team members, e.g.
•Respiratory System: VAP bundle with RT and nurse
•Need for intravascular devices/urinary catheter and skin assessment with nurse
•Physical therapy with physical therapist
•Medications with pharmacists
•Goals of care, need for palliative consult, disposition with all team members
50. Rounding Choreography
•Systems based assessment and plan
•Assessment and plan by systems:
•CNS
•Assessment: Slowly resolving coma secondary to hepatic encephalopathy,
sedative/opioid accumulation and a small hemorrhagic stroke
•Plan: Observe off all sedative agents, continue lactulose, MAP goals per neurology
(~150/90)
•CVS
•Respiratory
•Renal/Fluid status
•GI/ Endocrine (incl. stress ulcer prophylaxis, nutrition, glucose control)
•Hematology (incl. DVT prophylaxis)
•ID
•Skin and wound care issues
•Medications
•Devices
•Physical therapy
•Goals of care/psychosocial Issues
•Discharge planning
51. Rounding Choreography
•Systems based assessment and plan
•After presentation:
•Ask prompter to double check if any checklist items are missing
•Engage patient/family
•compassionately explain assessment and plan of care in layman terms
•ensure their concerns have been addressed
•schedule family meetings to discuss plan of care as needed
53. PROMPTER
•SIMULTANEOUSLY with admission and/or rounding:
•Check off items discussed and document assessment and plan in CERTAIN
- Speak up if items on the checklist are missed or need clarifications
•Document ordered and completed medications and interventions
54. PROMPTER (con’t)
•After admission and/or rounding
• Edit the automated admission or
progress note for printing or saving (pdf)
55.
56. Disclosure
• Research support from NIH, CMS, Philips Research North
America and Mayo Clinic
• IP rights for critical care related software tools
- The related research has been reviewed by the Mayo Clinic Conflict of
Interest Review Board and is being conducted in compliance with Mayo
Clinic Conflict of Interest policies. Mayo Clinic and Dr Gajic, Dr
Herasevich and Dr Pickering hold the patent application on AWARE
technology (US 2010/0198622, 12/697861, PCT/US2010/022750).
AWARE is licensed to Ambient Clinical Analytics Inc.
• No other financial relationships with commercial companies
and no other relevant disclosures
57. We need to be CERTAIN
…to prevent
DEATH
kojicic.marija@gmail.com
kashyap.rahul@mayo.edu
gajic.ognjen@mayo.edu
certain.tool@gmail.com
http://www.icertain.org/
(Diagnostic Errors and Therapeutic Harm)
Editor's Notes
We all know that critical care support for potentially reversible acute illness is one of the most cost effective interventions.
But, incomplete knowledge of best practices by frontline health care providers and delay or error-prone care delivery process sometime offsets the potential benefits of critical care support.
What we have learned from the practice in ICU care to date is if you do the right action at the right time especially early in the course of critical illness, the patients survive. Otherwise errors and delays in appropriate care is mostly related with poor outcomes and costly complications.
This is also a very well known issue since years and briefly emphasized in 1974 by Dr. Safar.
So, unfortunately we are just too late to implement the checklist approach in early hours of critical illness.
I will share the video soon. But I just want to underline some of the features of CERTAIN.
This is the main interface. There are three sections up to down. On the top, patient demographics, below that assessment section. And the rest is basically for the plan and recommendations.
Then, after a couple of different versions, we come up with this current version.
CERTAIN has two modules.
The ELITE module is mostly focuses on stabilization of the patient. Here, ELITE is the acronym for the evaluation of life threatening emergencies.
CERTAIN Rounds is the optimization module to be used during rounds.
I will share the video soon. But I just want to underline some of the features of CERTAIN.
This is the main interface. There are three sections up to down. On the top, patient demographics, below that assessment section. And the rest is basically for the plan and recommendations.
Under the assessment section, the user has a chance to highlight the current situation of the patient with regards to life threatening emergencies, ABCDEs along with the vitals and point of care labs.
Once a problem is identified, the user can access the decision support cards along with an orderset including suggested medications and interventions.
The medications and the interventions have also links to corresponding decision support cards, like the problems.
It is possible to order a medication or an intervention through those decision support cards and keep track of actions whıch are completed or which are not completed yet.
There is a timer embedded in the tool for timely actions like Intubation or CPR.
For now we have 15 ICUs from 4 contınents.
Initially we are planning to start in one in Serbia.
As an outcome assessment we will look for better care, better health and lower cost.
We make errors while managing patients because we are unaware of what is really going on and we are uncertain about what to do.
AWARE does an amazing job to fulfill the needs of the providers in terms of packaging and representing the relevant patient data.
But we also need a checklist for early recognition and treatment of acute illness, which is CERTAIN to prevent diagnostic errors and therapeutic harm.